Emerging data suggest Retatru tide , a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , may represent a promising step forward for weight management . Early patient investigations have indicated substantial decreases in body mass , potentially outperforming current body composition treatments. Neve